NCT00179504

Brief Summary

Stress contributes to health and behavioral issues in students, but will not be integrated into schools without evidence of benefit. This study was conducted to determine if a 6-week relaxation response (RR) curriculum improves cognitive performance in ninth grade students.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for phase_2 healthy

Timeline
Completed

Started Jul 2000

Longer than P75 for phase_2 healthy

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2000

Completed
5.2 years until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 16, 2005

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2007

Completed
Last Updated

November 5, 2007

Status Verified

November 1, 2007

First QC Date

September 13, 2005

Last Update Submit

November 2, 2007

Conditions

Outcome Measures

Primary Outcomes (1)

  • Determine if a 6-week relaxation response (RR) curriculum improves cognitive performance.

    6 weeks

Secondary Outcomes (1)

  • Evaluate whether the program would influence levels of salivary cortisol and whether there would be a correlation between cortisol levels and performance on the cognitive tasks.

    6 weeks

Interventions

Relaxation training

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • a member of 9th grade at a residential preparatory school.

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Jeffery A Dusek, PhD

    Beth Israel Deaconess Medical Center, Mind/Body Medical Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 16, 2005

Study Start

July 1, 2000

Study Completion

September 1, 2007

Last Updated

November 5, 2007

Record last verified: 2007-11